JP3835609B2 - Melanin production inhibitor - Google Patents
Melanin production inhibitor Download PDFInfo
- Publication number
- JP3835609B2 JP3835609B2 JP2003027707A JP2003027707A JP3835609B2 JP 3835609 B2 JP3835609 B2 JP 3835609B2 JP 2003027707 A JP2003027707 A JP 2003027707A JP 2003027707 A JP2003027707 A JP 2003027707A JP 3835609 B2 JP3835609 B2 JP 3835609B2
- Authority
- JP
- Japan
- Prior art keywords
- melanin production
- patent document
- production inhibitor
- melanin
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Cosmetics (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は、メラニン生成抑制剤、およびそれらを含有する香粧品に関するものである。
【0002】
【従来の技術】
従来、メラニンの生成を抑制するものとしては、メラノサイトに対する細胞毒性によるもの、メラノサイト内でのチロシナーゼの活性を抑制するものや、チロシナーゼの発現を抑制するもの、チロシナーゼ活性により生成したドーパキノンから、自動酸化によりメラニンに至る経路で、酸化を防止する方法が知られている。そして、細胞毒性によるメラニン生成抑制作用を示すものとしては、ハイドロキノン等が知られている。これらは、皮膚の色素沈着を軽減する目的で、色素沈着症の治療に使用されてきたが、安全性に問題がある。その誘導体として一般的に知られているアルブチン(非特許文献1)は、メラニンの生成を可逆的に抑制する物質として、一般に化粧品等に使用されている。
【0003】
その他メラニン生成抑制剤としては、例えば、システイン、グルタチオン、ビタミンC(非特許文献2)、コウジ酸(非特許文献3)、トリコデルマ属に属する微生物の産生物(特許文献1)、乳蛋白質のアルカリ分解物(特許文献2)、乳蛋白質の加水分解物(特許文献3)、コウジ酸のアミノ酸誘導体とペプチド誘導体(特許文献4)、メラニン生成抑制機能を有する香料化合物群(特許文献5)、チロシナーゼ活性阻害機能を有する香料化合物群(特許文献6、特許文献7)、各種植物抽出物等が知られている。
【0004】
しかしながら、これら従来のメラニン生成抑制剤は、ハイドロキノンの様に安全性に問題のあるものや、効果が実用上において満足できないものであり、真に満足できるものとはいえなかった。
【0005】
【特許文献1】
特開平2−145189号公報
【特許文献2】
特公昭58−17763号公報
【特許文献3】
特開平5−320068号公報
【特許文献4】
特開平4−187618号公報
【特許文献5】
特開2000−302642号公報
【特許文献6】
特開2001−163719号公報
【特許文献7】
特開2001−240528号公報
【非特許文献1】
富田健一、第20回FJセミナー予稿集、第21ページ、フレグランス・ジャーナル社、平成2年3月14日
【非特許文献2】
三島豊等、基礎皮膚化学、第258ページ、朝倉書店、昭和48年
【非特許文献3】
日経産業新聞、昭和63年5月24日
【0006】
【発明が解決しようとする課題】
本発明の目的は、安全で、かつ香粧品中に香粧品の品質を損なうことなく、任意の量を配合することができるメラニン生成抑制剤を提供することにある。
【0007】
【課題を解決するための手段】
本発明のメラニン生成抑制剤は、イソクロマン−1,3−ジオンを有効成分として含有するメラニン生成抑制剤であって、化粧品などの美白成分として極めて有用である。
【0009】
【発明の実施の形態】
本発明のメラニン生成抑制剤は、イソクロマン−1,3−ジオンを有効成分とするものである。
【0011】
本発明のメラニン生成抑制剤は、公知の方法により製造することができ、また、市販されている化合物もあるため、容易に入手することができる。
【0012】
本発明のメラニン生成抑制剤は、例えば、乳液、ローション、クリーム、パウダー、パック剤、皮膚洗浄剤、ペースト剤、ファンデーション、化粧水、ゲル剤などの化粧品、シャンプー、リンス、ボディーソープ、洗顔料等、石鹸などの身体洗浄剤、その他皮膚外用剤など、香粧品に好適に用いることができる。
【0013】
本発明のメラニン生成抑制剤の香粧品への配合割合は、任意に設定することができるが、0.00001%〜10質量重量%(以下単に「%」で表す)とすることが好ましく、0.0001〜5%とすることがさらに好ましく、特に好ましくは0.1〜1%であるい。また、本発明のメラニン生成抑制剤は、アルブチン、コウジ酸、アスコルビン酸など他のメラニン生成抑制剤と併用することもできる。また、たとえばビタミン、抗酸化剤、抗菌剤、抗炎症剤、紫外線吸収剤、冷感剤などの他の有効成分を配合することもできる。
【0014】
本発明のメラニン生成抑制剤は、メラニン生成抑制剤と基剤の組み合わせにより、一般的な分散化、可溶化技術を適宜選択することができる。具体的には、たとえば界面活性剤やその他可溶化剤などを使用する方法や、増粘剤などにより製剤の流動性を低下させるなどの手段によって、安定に分散化もしくは可溶化することができる。
【0015】
【実施例】
以下、本発明を実施例により具体的に説明するが、本発明はこれらによって何ら限定されるものではない。
【0016】
[実施例1] メラニン生成抑制効果
(試験方法)
0.1mol/LMリン酸バッファー(リン酸二水素カリウム:関東化学株式会社製、リン酸カリウム:和光純薬工業株式会社製)1.5ml、1.5mmol/LMチロシン(東京化成工業株式会社製)0.3ml、活性剤0.5mlを加え攪拌し、表1に示す各試料をエタノールで20倍に希釈したものを0.2ml加えた。液が透明になるまで攪拌し、マッシュルームチロシナーゼ(Sigma社製)を純水で3000units/mlに調整したもの0.3mlを加えた後、すばやく攪拌後、振盪恒温漕にて37℃で100分間インキュベートした。100分後、UV分光光度計(日本分光:UVIDEC−610C)を用いて波長640nmにおける吸光度を測定することにより、生成したメラニン量を求めた。チロシナーゼの代わりにバッファーを0.3ml加えたものをサンプルごとに測定しブランクとし、対照として、上記試料液の代わりにエタノールを加え同様に測定し、コントロールとした。
【0017】
(抑制率計算式)
メラニン生成抑制率(%)=(A −(C−B))/A×100(但し、A:コントロールの吸光度、B:ブランクの吸光度、C:サンプルの吸光度)
結果を表1に示す。
【0018】
[実施例2] IC50の測定
(試験方法)
0.1mol/LMリン酸バッファー(リン酸二水素カリウム:関東化学株式会社製、リン酸カリウム:和光純薬工業株式会社製)1.5ml、1.5mmol/LMチロシン(東京化成工業株式会社製)0.3ml、活性剤0.5mlを加え攪拌し、サンプルをエタノールで希釈したものを0.2ml加え、サンプルの濃度を変えたものを調整した。これらを液が透明になるまで攪拌し、マッシュルームチロシナーゼ(Sigma社製)を純水で3000units/mlに調整したもの0.3mlを加えた後、すばやく攪拌後、振盪恒温漕にて37℃で100分間インキュベートした。100分後、UV分光光度計(日本分光:UVIDEC−610C)を用いて波長640nmにおける吸光度を測定した。チロシナーゼの代わりにバッファーを0.3ml加えたものをサンプルごとに測定しブランクとし、対照として、上記試料液の代わりにエタノールを加え同様に測定し、コントロールとした。
【0019】
(IC50計算式)
メラニン生成抑制率(%)=(A −(C−B))/A×100(但し、A:コントロールの吸光度、B:ブランクの吸光度、C:サンプルの吸光度)
横軸に濃度、縦軸にメラニン生成抑制率をプロットしたグラフを作成し、このグラフからメラニン生成を50%抑制する濃度(以後、IC50と表す。)を求めた。
結果を表1に示す。
【0020】
【表1】
表1の結果から明らかなように、本発明のメラニン生成抑制剤を添加した溶液において、メラニンの生成は抑制された。さらにその効果は、既知の物質のアルブチンやコウジ酸と同等のものであった。
【0021】
【発明の効果】
本発明のイソクロマン−1,3−ジオンは、高いメラニン生成抑制効果を有し、それ自身の香気強度が低いため、香粧品の品質を損なったり、香粧品の香りのバリエーションを限定することがなく、任意の量を配合することが可能であり、香粧品中に安全に用いることができる。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to melanin production inhibitors and cosmetics containing them.
[0002]
[Prior art]
Conventionally, the suppression of melanin production is due to cytotoxicity to melanocytes, the suppression of tyrosinase activity in melanocytes, the suppression of tyrosinase expression, the autooxidation from dopaquinone generated by tyrosinase activity There is known a method for preventing oxidation through a route leading to melanin. And hydroquinone etc. are known as what shows the melanin production suppression effect by cytotoxicity. They have been used to treat pigmentation for the purpose of reducing skin pigmentation, but have safety issues. Arbutin (Non-patent Document 1), which is generally known as a derivative thereof, is generally used in cosmetics and the like as a substance that reversibly suppresses the production of melanin.
[0003]
Other melanin production inhibitors include, for example, cysteine, glutathione, vitamin C (non-patent document 2), kojic acid (non-patent document 3), products of microorganisms belonging to the genus Trichoderma (patent document 1), and alkalis of milk proteins. Decomposed product (Patent Document 2), milk protein hydrolyzate (Patent Document 3), amino acid derivative and peptide derivative of kojic acid (Patent Document 4), fragrance compound group having melanin production inhibitory function (Patent Document 5), tyrosinase A group of perfume compounds having an activity-inhibiting function (Patent Documents 6 and 7), various plant extracts, and the like are known.
[0004]
However, these conventional melanin production inhibitors, such as hydroquinone, have safety problems and are unsatisfactory in practical use and cannot be said to be truly satisfactory.
[0005]
[Patent Document 1]
Japanese Patent Laid-Open No. 2-145189 [Patent Document 2]
Japanese Patent Publication No.58-17773 [Patent Document 3]
JP-A-5-320068 [Patent Document 4]
JP-A-4-187618 [Patent Document 5]
JP 2000-302642 A [Patent Document 6]
JP 2001-163719 A [Patent Document 7]
JP 2001-240528 A [Non-Patent Document 1]
Kenichi Tomita, 20th FJ Seminar Proceedings, Page 21, Fragrance Journal, March 14, 1990 [Non-Patent Document 2]
Mishima Yutaka et al., Basic Dermatology, page 258, Asakura Shoten, 1973 [Non-patent Document 3]
Nikkei Business Daily, May 24, 1988 [0006]
[Problems to be solved by the invention]
An object of the present invention is to provide a melanin production inhibitor that is safe and can be incorporated in an arbitrary amount in a cosmetic product without impairing the quality of the cosmetic product.
[0007]
[Means for Solving the Problems]
The melanin production inhibitor of the present invention is a melanin production inhibitor containing isochroman-1,3-dione as an active ingredient, and is extremely useful as a whitening component for cosmetics and the like.
[0009]
DETAILED DESCRIPTION OF THE INVENTION
The melanin production inhibitor of the present invention contains isochroman-1,3-dione as an active ingredient.
[0011]
The melanin production inhibitor of the present invention can be produced by a known method and can be easily obtained because some compounds are commercially available.
[0012]
Examples of the melanin production inhibitor of the present invention include emulsions, lotions, creams, powders, packs, skin cleansers, pastes, foundations, lotions, gels, and other cosmetics, shampoos, rinses, body soaps, facial cleansers, etc. It can be suitably used for cosmetics such as soaps and other body cleansing agents and other skin external preparations.
[0013]
The blending ratio of the melanin production inhibitor of the present invention into the cosmetic can be arbitrarily set, but is preferably 0.00001% to 10% by weight (hereinafter simply referred to as “%”). More preferably, the content is 0.0001 to 5%, particularly preferably 0.1 to 1%. The melanin production inhibitor of the present invention can be used in combination with other melanin production inhibitors such as arbutin, kojic acid, and ascorbic acid. In addition, other active ingredients such as vitamins, antioxidants, antibacterial agents, anti-inflammatory agents, ultraviolet absorbers, and cooling agents can also be blended.
[0014]
The melanin production inhibitor of the present invention can be appropriately selected from general dispersion and solubilization techniques depending on the combination of the melanin production inhibitor and the base. Specifically, it can be stably dispersed or solubilized by, for example, a method using a surfactant or other solubilizer, or a means such as reducing the fluidity of the preparation with a thickener or the like.
[0015]
【Example】
EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but the present invention is not limited to these examples.
[0016]
[Example 1] Melanin production inhibitory effect (test method)
0.1 mol / LM phosphate buffer (potassium dihydrogen phosphate: manufactured by Kanto Chemical Co., Inc., potassium phosphate: manufactured by Wako Pure Chemical Industries, Ltd.) 1.5 ml, 1.5 mmol / LM tyrosine (manufactured by Tokyo Chemical Industry Co., Ltd.) ) 0.3 ml and 0.5 ml of activator were added and stirred, and 0.2 ml of each sample shown in Table 1 diluted 20-fold with ethanol was added. Stir until the solution becomes clear, add 0.3 ml of mushroom tyrosinase (Sigma) adjusted to 3000 units / ml with pure water, quickly stir, and then incubate at 37 ° C for 100 minutes in a shaking thermostat. did. After 100 minutes, the amount of melanin produced was determined by measuring the absorbance at a wavelength of 640 nm using a UV spectrophotometer (JASCO: UVIDEC-610C). A sample obtained by adding 0.3 ml of buffer instead of tyrosinase was measured for each sample and used as a blank, and as a control, ethanol was added instead of the sample solution and the same measurement was performed as a control.
[0017]
(Suppression rate calculation formula)
Melanin inhibition rate (%) = (A− (CB)) / A × 100 (A: absorbance of control, B: absorbance of blank, C: absorbance of sample)
The results are shown in Table 1.
[0018]
[Example 2] Measurement of IC50 (test method)
0.1 mol / LM phosphate buffer (potassium dihydrogen phosphate: manufactured by Kanto Chemical Co., Inc., potassium phosphate: manufactured by Wako Pure Chemical Industries, Ltd.) 1.5 ml, 1.5 mmol / LM tyrosine (manufactured by Tokyo Chemical Industry Co., Ltd.) ) 0.3 ml and 0.5 ml of activator were added and stirred, and 0.2 ml of a sample diluted with ethanol was added to adjust the sample concentration. These were stirred until the solution became transparent, 0.3 ml of mushroom tyrosinase (manufactured by Sigma) adjusted to 3000 units / ml with pure water was added, and after rapid stirring, 100 ° C. at 37 ° C. with a shaking constant temperature bath. Incubated for minutes. After 100 minutes, the absorbance at a wavelength of 640 nm was measured using a UV spectrophotometer (JASCO: UVIDEC-610C). A sample obtained by adding 0.3 ml of buffer instead of tyrosinase was measured for each sample and used as a blank, and as a control, ethanol was added instead of the sample solution and the same measurement was performed as a control.
[0019]
(IC50 calculation formula)
Melanin inhibition rate (%) = (A− (CB)) / A × 100 (A: absorbance of control, B: absorbance of blank, C: absorbance of sample)
A graph was prepared by plotting the concentration on the horizontal axis and the melanin production inhibition rate on the vertical axis, and the concentration at which melanin production was inhibited by 50% (hereinafter referred to as IC50) was determined from this graph.
The results are shown in Table 1.
[0020]
[Table 1]
As is apparent from the results in Table 1, the production of melanin was suppressed in the solution to which the melanin production inhibitor of the present invention was added. Furthermore, the effect was equivalent to the known substances arbutin and kojic acid.
[0021]
【The invention's effect】
Since the isochroman-1,3-dione of the present invention has a high melanin production inhibitory effect and its own fragrance intensity is low, it does not impair the quality of the cosmetic product or limit variations in the fragrance of the cosmetic product. Any amount can be blended and can be used safely in cosmetics.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003027707A JP3835609B2 (en) | 2003-02-05 | 2003-02-05 | Melanin production inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003027707A JP3835609B2 (en) | 2003-02-05 | 2003-02-05 | Melanin production inhibitor |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006024051A Division JP4382758B2 (en) | 2006-02-01 | 2006-02-01 | Melanin production inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004238309A JP2004238309A (en) | 2004-08-26 |
JP3835609B2 true JP3835609B2 (en) | 2006-10-18 |
Family
ID=32955350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003027707A Expired - Fee Related JP3835609B2 (en) | 2003-02-05 | 2003-02-05 | Melanin production inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3835609B2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0520368D0 (en) * | 2005-10-06 | 2005-11-16 | Univ Aston | Antibacterial pyrrols |
JP2009221179A (en) * | 2008-03-19 | 2009-10-01 | Kose Corp | Skin whitening agent containing maleic acid as active ingredient |
JP5925028B2 (en) * | 2011-09-01 | 2016-05-25 | 花王株式会社 | Skin lightening agent |
WO2017097434A1 (en) * | 2015-12-06 | 2017-06-15 | Symrise Ag | A fragrance composition |
GB201521861D0 (en) * | 2015-12-11 | 2016-01-27 | Givaudan Sa | Improvements in or relating to organic compounds |
KR102186696B1 (en) * | 2019-08-08 | 2020-12-04 | 주식회사 스템모어 | Composition for whitening comprising dihydro-5-methylfuran-2(3h)-one derivatives |
WO2021211982A2 (en) * | 2020-04-17 | 2021-10-21 | Oregon State University | Regioselective synthesis of substituted compounds |
-
2003
- 2003-02-05 JP JP2003027707A patent/JP3835609B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2004238309A (en) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04210902A (en) | Skin care composition | |
WO2003013439A3 (en) | Anti-irritants | |
JP2016539987A (en) | Exfoliating hair retention promoting formulation | |
JP3835609B2 (en) | Melanin production inhibitor | |
CN113101236A (en) | Instant mixed and used whitening essence with multiple antioxidation effects and preparation method thereof | |
JPH0545569B2 (en) | ||
JPH0532533A (en) | Cosmetic | |
JP4187707B2 (en) | Melanin production inhibitor | |
JPH02111714A (en) | Cosmetic | |
JP4382758B2 (en) | Melanin production inhibitor | |
ZA202301114B (en) | Branched amino acid surfactants for personal care and cosmetic products | |
JPH0245408A (en) | Skin-beautifying cosmetic | |
JP4169277B2 (en) | Melanin production inhibitor | |
JP5201859B2 (en) | Fragrance composition | |
JP4235602B2 (en) | Melanin production inhibitor and topical skin preparation | |
JP2589761B2 (en) | Cosmetic additives | |
JPH0892062A (en) | External preparation | |
JPH11292752A (en) | Beautifully whitening agent and composition for external use for skin | |
JP3829305B2 (en) | Melanin production inhibitor | |
JP4140024B2 (en) | Melanin production inhibitor | |
JPH11286425A (en) | Composition for suppressing aged person smell | |
JP5011470B2 (en) | Melanin production inhibitor | |
JPH08175951A (en) | Skin preparation for external use | |
JPH01256586A (en) | Antioxidant composition | |
JP4169278B2 (en) | Melanin production inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20040927 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040928 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050322 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20051207 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060201 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060221 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060714 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060719 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 3835609 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100804 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100804 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110804 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120804 Year of fee payment: 6 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120804 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130804 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |